Paola Antonini

Paola Antonini's work experience includes their current role as Chief Scientific Officer at Meditrial since April 2022. Prior to this, they held the position of VP of Clinical Science at Telix Pharmaceuticals Limited starting from October 2021. Paola also worked as CMSO at Great Health Science from April 2021. Before that, they served as the Head of Clinical Research at Great Health Science from January 2021. Additionally, Paola Antonini was the Director of Research Project in Longevity - Epidemiological study at CIAO study from January 2016. Paola was the Global Head of Clinical Science at Almirall from July 2020 to December 2020. Paola also worked as the Medical Director at Nouscom AG from January 2019 to June 2020. Other positions held by Antonini include being the Scientific Coordinator at GREAT Network Italy from February 2018 to December 2018. Paola held various roles at Worldwide Clinical Trials, including Sr VP Scientific Affairs from February 2013 to August 2016. Paola also served in several positions at Merck Sharp & Dohme Italy, starting as the Medical Affairs Director in July 1983 and ending as the Clinical Research Manager in December 1996.

Paola Antonini's education history begins in 1978 when they enrolled at Sapienza Università di Roma to pursue a degree in Medicine. Paola completed their MD program in 1983. Following this, from 1983 to 1987, Paola Antonini attended Università degli Studi di Firenze, specializing in Pharmacology as part of their medical studies. It is unclear when their time at Università degli Studi di Firenze ended and if they obtained any further degrees or field of study.